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Abstract: Objective:  The main objective of this cross sectional study is to assess the cardiac
autonomic neural activity in the presence of abnormally increased body weight in
youths and its relationship to metabolic risk factors and cardiorespiratory fitness.
Methods: Sixty-four overweight and obese subjects, 9 to 17 years, of both sexes,
stratified according to the international body mass index cut-off, were enrolled.
Continuous electrocardiogram was recorded during 15 minutes in resting conditions,
and the heart rate variability was measured in the time domain, frequency domain and
for non-linear dynamics. In addition, cardiometabolic risk factors, and cardiorespiratory
fitness in effort conditions were assessed. Results: Among the overweight and obese
youths, no significant differences were observed regarding metabolic parameters and
heart rate, although cardiorespiratory fitness was the lowest in the severe obese.
Likewise, no significant differences were observed in heart rate variability, independent
of how it was assessed. A positive and significant relationship, independent of the
degree of obesity, pubertal stage and breathing rate under resting conditions, has been
observed between sympatho-vagal balance, insulin and the HOMA index.
Furthermore, cardiorespiratory fitness assessed by VO2peak was associated with
insulin levels (r=-0.273; p<0.05), the standard deviation of the NN interval (SDNN:
r=0.268, p<0.05) and the long term variation using the Poincaré plot (PS1: r=0.275,
p<0.05; PS2 r=0.273, p<0.05).
Conclusion: The key findings of the present study were the presence of a link between
fasting insulin, heart rate variability and cardiorespiratory fitness independent of the
degree of obesity, indicating the heterogeneity of obese children and adolescents.
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ABBREVIATIONS 
ANS - Autonomic nervous system 
BMI – Body mass index 
BP – Blood pressure 
BR - Breathing rate 
CRF - Cardiorespiratory fitness 
cANS - Cardiac autonomic nervous system 
DBP – Diastolic blood pressure 
HF - High frequency 
HOMA - Homeostatic model assessment  
HR – Heart rate 
HRV – Heart rate variability 
HTN – Hypertension 
LF - Low frequency 
PSD - Power spectral density 
SampEn - Sample entropy  
SBP – Systolic blood pressure 
SNS - Sympathetic nervous system 
VO2 – Volume oxygen  
Abbreviations definition list
CONDENSED ABSTRACT 
This cross sectional study is to assess the cardiac autonomic neural activity and its 
relationship with metabolic risk factors and cardiorespiratory fitness in the presence of 
abnormally increased body weight in youths. The key findings of the present study 
were the presence of a link between fasting insulin, heart rate variability and 
cardiorespiratory fitness. Increased fasting insulin is associated with higher sympatho-
vagal balance and lower cardiorespiratory fitness independently of the degree of 
obesity indicating the heterogeneity of obese children and adolescents. Better 
knowledge of the presence of cardiometabolic risk factors may contribute to the 
enhancement of the treatment´s efficiency in obese youth and consequently, to 
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This cross sectional study is to assess the cardiac autonomic neural activity and its 
relationship with metabolic risk factors and cardiorespiratory fitness in the presence of 
abnormally increased body weight in youths. The key findings of the present study 
were the presence of a link between fasting insulin, heart rate variability and 
cardiorespiratory fitness. Increased fasting insulin is associated with higher sympatho-
vagal balance and lower cardiorespiratory fitness independently of the degree of 
obesity indicating the heterogeneity of obese children and adolescents. Better 
knowledge of the presence of cardiometabolic risk factors may contribute to the 
enhancement of the treatment´s efficiency in obese youth and consequently, to 
















Objective:  The main objective of this cross sectional study is to assess the cardiac 
autonomic neural activity in the presence of abnormally increased body weight in 
youths and its relationship to metabolic risk factors and cardiorespiratory fitness. 
Methods: Sixty-four overweight and obese subjects, 9 to 17 years, of both sexes, 
stratified according to the international body mass index cut-off, were enrolled. 
Continuous electrocardiogram was recorded during 15 minutes in resting conditions, 
and the heart rate variability was measured in the time domain, frequency domain and 
for non-linear dynamics. In addition, cardiometabolic risk factors, and 
cardiorespiratory fitness in effort conditions were assessed. Results: Among the 
overweight and obese youths, no significant differences were observed regarding 
metabolic parameters and heart rate, although cardiorespiratory fitness was the 
lowest in the severe obese. Likewise, no significant differences were observed in heart 
rate variability, independent of how it was assessed. A positive and significant 
relationship, independent of the degree of obesity, pubertal stage and breathing rate 
under resting conditions, has been observed between sympatho-vagal balance, insulin 
and the HOMA index. Furthermore, cardiorespiratory fitness assessed by VO2peak was 
associated with insulin levels (r=-0.273; p<0.05), the standard deviation of the NN 
interval (SDNN: r=0.268, p<0.05) and the long term variation using the Poincaré plot 
(PS1: r=0.275, p<0.05; PS2 r=0.273, p<0.05). 
Conclusion: The key findings of the present study were the presence of a link between 
fasting insulin, heart rate variability and cardiorespiratory fitness independent of the 









Recent years have seen a rapid worldwide increase in obesity, especially among 
children and young people [1]. The adverse effects of weight gain on metabolic and 
cardiovascular function and the association of weight gain with a higher incidence of 
health problems later in life represent major issues in health care which have 
generated great concern over the last few years [2-5]. Indeed, considering the 
increasing tendency for obesity to appear during childhood and to track, to some 
extent, into adult life [6-8], as well as the firmly established relationships among 
obesity, type 2 diabetes, and hypertension (HTN) in adults, obese children appear to 
be at particularly high risk of becoming diabetic and hypertensive as they age.  
 
Hyperinsulinemia, high blood pressure (BP) and reduction in cardiovascular fitness are 
all associated with overweight and obesity. In a recent study [9], with 611 obese 
youths, 39%, 16.5% and 2.8% of this population presented 1, 2 or 3 risk factors, 
respectively, with hyperinsulinemia being the most prevalent, followed by lipid 
abnormalities and high BP. Moreover, obesity is inversely related to cardiorespiratory 
fitness (CRF), and when expressed by oxygen consumption during the effort test 
(VO2peak), it is a marker of cardiovascular morbidity and mortality [10]. 
 
The association between obesity and cardiometabolic risk factors, however, differs 
among obese patients. While some subjects with a mild degree of obesity have an 
increment in risk, others do not, even though they have a higher degree of obesity so, 
as a consequence, the concept of “healthy” obese has been proposed [11]. The 
challenge is to find out whether altered underlying mechanisms are present in order to 
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optimize interventions. Therefore, identifying these potential intermediate 
mechanisms for the development of cardiometabolic abnormalities may define a high 
risk group in obese youth. 
 
One of the potential mechanisms which could contribute to the cardiometabolic 
alterations is the imbalance in the activity of the autonomic nervous system (ANS). 
Experimental and clinical studies with overweight and obese populations have related 
autonomic nervous activity to obesity, mainly the sympathetic nervous system (SNS) 
[12-16]. The role of the autonomic imbalance in the over activity of the SNS, on BP 
values [15], hyperinsulinemia [14] and cardiorespiratory fitness has been studied in the 
adult population [17]; however, studies in children are scarce [18]. The main objective 
of this cross sectional study is to assess the cardiac ANS activity in the presence of 
abnormally increased body weight in youths and its relationship with metabolic risk 
factors BP and CRF.  
 
SUBJECTS AND METHODS 
Sixty-Four overweight and obese, 9 to 17 years old, of both sexes, from those who 
underwent an assessment of overweight/obesity in the Pediatric Department of the 
Consorcio Hospital General de Valencia (Spain) were enrolled. None of them had 
secondary obesity syndromes suffered from acute or chronic disease or had enrolled in 
weight loss programmes. Data about physical activity was obtained from physician-
patient clinical interviews. Anthropometric parameters, BP measurements and 
metabolic profile were assessed. In addition, heart rate (HR) and respiratory rate (BR) 
were measured in resting and effort conditions. While HRV was performed exclusively 
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under resting conditions from the recorded ECG signal, the CRF was evaluated as 
oxygen consumption during the effort test. The protocol was approved by the Ethical 
Committee of the Consorcio Hospital General de Valencia and a consent form was 
signed by the parents and the participants.  
 
Anthropometrics: 
Body weight was recorded to the nearest 0.1 kg using a standard beam balance scale 
with the individuals wearing light indoor clothing and no shoes. Height was recorded 
to the nearest 0.5 cm using a standardized wall-mounted height board.  Overweight 
and obesity have been qualified based on the recently published extended 
international (IOTF) body mass index cut-offs for thinness, overweight and obesity in 
children [19]. In this case, BMI values for age and sex between 25 and 30 are 
overweight, between 30 and 35 are obese and above 35 are morbid obese. Waist 
circumference was measured at the midpoint between the iliac crest and the costal 
margin in the mid-axillary line in the standing position at the end of a gentle 
expiration. Height and waist ratio was calculated.  
 
Blood pressure measurement and metabolic assessment 
Following the published recommendations of the European Society of Hypertension 
Guidelines [20], trained nurses measured the BP of each individual three times 
consecutively in the seated position at five minute intervals. Office BP was taken as the 
mean of the three measurements. Hypertension was defined when SBP and/or DBP 
were persistently higher than the 95th percentile specific for age, sex and height [20]. 
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Individuals were considered normotensive when both SBP and DBP were less than the 
90th for age, sex and height. 
 
Metabolic assessment was performed under fasting conditions in the early morning. 
Peripheral blood samples were obtained to measure glucose by the glucose oxidase 
method (Beckman Glucose Analyzer, Beckman Instruments, Fullerton, CA, USA) [21], 
insulin (Pharmacia Insulin RIA kit; Uppsala, Sweden) [22] and lipid profile. Homeostatic 
model assessment for insulin resistance (HOMA-IR) index was calculated by dividing 
the product of insulin (microunits per milliliter) and glucose (millimoles per liter) by 
22.5 [23]. Hyperinsulinism was defined from norms for pubertal stage [4,24,25]. 
Abnormal fasting lipids were defined from normative data [26].  
 
Monitoring Heart Rate Variability and Cardio Respiratory Fitness in resting and effort 
conditions 
The heart rate, BR and ECG signal, under resting conditions, were continuously 
measured and recorded using a TIPS shirt. The procedure lasted 15 minutes in which 
the patient, in fasting conditions, remained lying down in a quiet room at 23ºC 
temperature, following the recommendations summarized in Guixeres, et al. [27]. 
 
Cardiorespiratory fitness was measured according to a modified version of the Balke 
protocol for treadmills which consisted of two phases: an initial 3-min warm-up and 
the effort stage which lasted until the subject reaches 90% of the maximum theoretical 
HR.  The (HR)peak, the (BR)peak and the (VO2)peak are the corresponding values when the 
stopping criterion was reached. All the participants reached the stopping criterion of 
9 
 
the effort test. In addition, the BP [(Systolic BP)peak and (Diastolic BP)peak] were 
measured [28].  
 
Heart rate variability assessment 
The HRV of all the participants was analysed from the continuous 15 minute ECG signal 
recorded under resting conditions following the recommendations previously 
published [29-31]. These analyses have been performed in the time and frequency 
domain as well as in that regarding non-linear dynamics.  
 
Time domain analyses include statistical and geometric methods directly calculated 
from the inter-beat interval time-dependant series. Special attention was paid to the 
standard deviation of the NN interval series (SDNN). Frequency domain analyses used 
to calculate the total power spectral density (PSD), as well as the power density 
corresponding to low frequency (LF) and high frequency (HF), were performed using 
the Lomb-Scargle method. Both absolute (aLF, aHF and aTotal), as well as normalized 
values (nLF, nHF and LF/HF) are presented. It is worth noting that the intervals 
considered for LF and HF are 0.04-0.15 and 0.15-1, respectively. 
 
Non-linear dynamics were studied from the ECG signal using entropy base measures 
(sample entropy), Poincaré plot (PS) and fractal base measures (Detrended Fluctuation 
Analyses, DFA). While the first of them calculates the complexity of the whole signal, 
the other two differentiate between short and long term variation. To distinguish 
between them, a subscript 1 or 2 following the name of the procedure is used (i.e: P S1: 
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short term variation according to the Poincaré plot procedure, P S2: long term variation 
according to the Poincaré Plot).  
 
Statistical analysis 
The results were statistically analysed using SPSS version 16 (SPSS Inc., Chicago, Illinois, 
USA). Shapiro-Wilk and normal Q-Q plots were used to analyse the degree of normal 
distribution of the study population. One-way ANOVA was used to compare 
quantitative variables, followed by Bonferroni’s correction to control for multiple 
comparisons. Bi-variate partial correlation tests were performed to assess 
relationships among the different variables. Obesity degree, BR and Pubertal stage 





General characteristics of the study population 
A total of 64 young Caucasian individuals were included in the study, of whom 14 
(22%) were overweight, 33 (51%) were moderately obese and 17 (27%) severely obese. 
No differences in age and sex distribution among groups were detected. Six subjects 
were hypertensive. All youth included in this cohort manifested a lack of physical 
activity other than the mandatory school activities. The general characteristics of the 
study population grouped by overweight and degree of obesity have been summarized 




No significant differences were observed in insulin, HOMA-IR, fasting glucose, lipid 
profile, breath rate or in BP and HR under resting conditions. Despite the absence of 
statistical significance, severely obese subjects tend to have the highest values of 
insulin, HOMA-IR and systolic BP. Under effort conditions, however, significant 
differences in VO2peak, were observed between obese and overweight, BR and diastolic 
BP for the obese groups.  
 
Heart rate variability,   
Heart rate variability in the time and frequency domain and its non-linear components 
were analysed. All these parameters are summarized for each of the groups in Table 2. 
Significant differences were observed in the total power spectral density -calculated 
using the Lomb-Scargle method - between the moderate and severe obese. The rest of 
the parameters do not seem to follow well-defined trends. This suggests that obesity 
by itself is not responsible for altering cANS activity.  
 
Heart rate variability, metabolic profile and CRF   
The association of HRV parameters with metabolic profile, BP values and CRF were 
assessed by Pearson´s correlation coefficients in subjects excluding the hypertensives 
(Table 3). Obesity degree, pubertal stage and BR at rest were considered cofounders. 
Only normotensive subjects were included because of the bias HTN may introduce to 
the results of HRV assessment.  
 
Fasting insulin and HOMA-IR have presented significant positive correlations with the 
sympatho-vagal balance (LS_LF/HF: r=0.281, p<0.05; r=0.304, p<0.05, respectively); 
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however, no significant relationship was observed with BP at rest or under effort 
conditions.  
 
Cardiorespiratory fitness, assessed by VO2peak, was associated with the standard 
deviation of the NN interval (SDNN: r=0.268, p<0.05) and with the long-term variation 
using the Poincaré plot (PS1: r=0.275, p<0.05; P S2 r=0.273, p<0.05). These are in 
agreement with the fact that higher ECG signal complexity is expected in subjects with 
a lower degree of obesity. Finally, VO2peak was significantly associated with insulin (r=-
0.273; p<0.05), although with HOMA-IR it shows a trend (r=-0.236; p<0.09) when 
adjusted by degree of obesity, pubertal stage and BR in effort. 
 
Multivariant analysis relating the three components, metabolic (insulin levels), HRV 
(LS_LF/HF) and the CRF (VO2peak) and confounders has been performed. Insulin levels 
were independently related to LF/HF (p=0.003), VO2peak (p=0.028), pubertal stage 
(p=0.014) and BR at exercise (p=0.016). These factors explain 35% of the variance. 




In a pediatric population with a wide age range and BMI distribution, from overweight 
to severely obese, the activity of cANS was assessed through the HRV analysis of the 
ECG signal recorded under resting conditions. The key findings of the present study 
were the presence of a link between fasting insulin, HRV and CRF. Increased fasting 
insulin was associated with a higher sympatho-vagal balance and lower CRF, 
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independent of the degree of obesity and puberty, indicating the heterogeneity of 
obese children and adolescents. 
 
The study was performed in a cohort of overweight and obese individuals recruited 
from an obesity clinic and may not be representative of the general population. Six 
subjects (10%) were diagnosed with HTN. The overweight and obese population has 
been qualified following the new extended international body mass index cut-offs (19). 
Even though this reformulation is expected to lead to minor changes in existing 
thresholds, the main benefits among others are, its capability to be compared directly 
with the international and WHO cut-offs and the fact that they are exclusively for 
children and are not linked to the corresponding adult BMI values.  
 
Obesity is an increasingly prevalent condition which predisposes to the presence of 
cardiometabolic risk factors, hyperinsulinemia, HTN and lipid abnormalities [9]. It is 
important to reinforce that the present study was performed in a pediatric population 
in which comorbidities were not yet fully established. Data show that insulin levels 
correlate with cANS activity, measured in the frequency domain, independent of the 
degree of obesity and the pubertal stage. This finding coupled with non-significant 
differences of insulin levels between overweight and obese subjects, points out the 
potential role of cANS activity in the dysmetabolic state. While some studies [32-34] 
have concluded that insulin may trigger sympathetic excitatory effects on central 
adrenergic neural outflow, in others an increased adrenergic state has shown per se to 




In addition to the evaluation of traditional parameters, the effort test, CRF, has been 
added and assessed by oxygen consumption, (VO2peak. In the evaluation of 
overweight/obese children and adolescents the assessment of CRF is regularly not 
included, even though the information gained can be relevant when categorizing the 
risk of obese subjects [10]. The effort test was performed using a modified Balke 
protocol suited for children and adolescents in which the speed and the inclination 
profile were modified. The main purpose of these modifications was to assure a more 
secure environment for the subjects participating in the study and to avoid reaching 
extenuation. Despite them, the procedure retains its discriminatory effect as described 
in Guixeres et al. [27]. During the exercise, lower (VO2peak was observed in obese 
subjects as compared with overweight ones, indicating the poorest CRF performance is 
most evident in the severely obese.  
 
Studies performed in adults [36] and recently in non-obese children [37] have related 
low (VO2peak with life expectancy in adults and metabolic abnormalities, like insulin 
resistance in children, respectively. In the present research, this finding has also been 
demonstrated, but in this case in the obese pediatric population. The low (VO2peak is 
inversely associated with fasting insulin, indicating that the lower the CRF the higher 
the risk for insulin resistance at this early stage of life and foreseeing the future risk to 
develop metabolic syndrome and type 2 diabetes. The concurrence of low CRF, high 
levels of insulin and diastolic BP values indicates the presence of subtle derangements 
of the cardiometabolic status, predicting a future increment of cardiovascular risk. 
Consequently, CRF is a relevant clinical parameter that could be included into the 




Autonomic nervous system imbalance, assessed in the heart, may not only contribute 
to the development or stabilization of obesity (38,39) but it is also associated with 
cardiovascular mortality (40). Therefore, the study of the ANS function in the presence 
of obesity is of considerable clinical interest. Currently, several procedures [41-43] 
have been developed to assess the ANS activity. Nowadays, HRV has become one of 
the most popular methods (cANS), because it is simple, reliable and non-invasive. The 
HRV assessment is based on the NN interval duration in ECG, reflecting the complex 
interactions between the SNS and the parasympathetic one.   
 
In general, time and frequency domain analyses have been applied to assess the 
activity of ANS [41]. Moreover, an analysis performed by non-linear dynamics is 
becoming more frequent as complementary information [43,44]. The increment of 
cANS in those subjects with elevated insulin levels suggests that obesity itself does not 
alter the ECG signal variability in contrast with metabolic factors. These data are 
partially in agreement with the study of Baum et al. in which an ANS dysfunction was 
described in obese children and adolescents [45]. These data are partially in 
agreement with those of the study by Baum et al. in which an ANS dysfunction was 
described in obese children and adolescents [45]. Autonomic nervous system 
dysfunction, was characterized by both parasympathetic and sympathetic activity 
reduction, although the LF/LH ratio was positively related to body weight. Similarly, 




Non-linear dynamics evaluated with the Poincaré plot method have shown a positive 
correlation with VO2peak. The fact that both short and long term variations are 
positively related highlights the relationship between signal complexity and CRF [44]. 
Several studies have associated these variations with parasympathetic activity (PS1) 
and sympathetic modulation (PS2) [47] or as an indicator of vagal modulation (PS1) 
[48]. In either case, higher activity is associated with healthier subjects which at the 
end reach higher VO2peak values reflecting better CRF conditions. This is confirmed by 
the positive correlation between SDNN and VO2peak.  The coherence of these findings 
highlights the robustness of the Poincaré plot procedure in analysing non-linear 
dynamics under resting conditions and its application for predicting CRFs in an 
overweight and obese youth.     
 
Strengths and limitations of the present research need to be considered. Being a cross-
sectional study with a limited sample size does not allow for casual relationships 
among the parameters tested. Data from clinical samples may not be representative of 
the general population, and selection and referral bias was present. Moreover, no 
information about the duration of obesity was available, a factor that can influence 
cANS. The lack of physical activity, other than that mandatory at school was common 
for all subjects. Combining the information of traditional parameters with those 
coming from the assessment of cANS in a cohort of young people with a wide BMI 
distribution and heterogeneous metabolic abnormalities contributes relevant 
information to the link between the cANS activity, metabolic status and CRF, 




The present work deals with an under investigated area in pediatric patients, adding 
significant insights into the links among metabolic parameters, CRF and HRV in the 
presence of abnormally increased body weight. In addition, it reflects the 
heterogeneity of obese subjects with autonomic imbalance and the association of this 
latter one with cardiometabolic risk factors. Better knowledge of the presence of 
cardiometabolic risk factors may contribute to an enhancement of treatment 
efficiency in obese youth, and consequently improve prognosis and quality of life in 
adulthood. Longitudinal studies should be performed to determine whether or not 
cANS imbalance can be a cause or a consequence of the metabolic and cardiovascular 
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LEGEND OF FIGURES 
 
Figure 1. Pearson´s correlation coefficients (p<0.05) showing the link between insulin, 
heart rate variability and cardiorespiratory fitness. All correlations were adjusted by 
degree of obesity, pubertal stage and BR (baseline when HRV and in effort when 
VO2peak was considered, respectively). 
Ω r denotes the relationship between LS_LF/HF and fasting insulin 
¥ r denotes the relationship between SDNN, Poincaré S1 and S2 
* r denotes the relationship between insulin and VO2peak 
See text for details 
 
Reviewer #1: 
The manuscript has improved, but still has several inaccuracies. 
 
* The purpose of the study is "to assess the cardiac ANS activity in the presence of abnormally 
increased body weight in youths and its relationship with metabolic risk factors, BP and CRF". 
Results demonstrate that insulin and HOMA are associated positively and independently of obesity 
degree, puberty and breathing rate with HRV and insulin is negatively associated with CRF. 
However, the association between CRF and insulin is not reported in the Abstract (only in 
condensed abstract). Furthermore, the relation between CRF and HOMA is not described and the 
negative correlation of insulin with CRF shown in Figure 1 does not seem to be adjusted for puberty 
and obesity (which is essential). This association must be also reported in the text of Results. 
 
 
The information requested has been added in the abstract “…VO2peak, was associated with 
insulin levels (r=-0.273; p<0.05)…” On page 12, first paragraph: “Finally, VO2peak was 
significantly associated with insulin (r=-0.273; p<0.05), although with HOMA-IR it shows a 
trend (r=-0.236; p<0.09) when adjusted by degree of obesity, pubertal stage and BR in 
effort.” 
 
The caption for Figure 1 has been revised to explain the confounders included. “Figure 1. 
Pearson´s correlation coefficients (p<0.05) showing the link between insulin, heart rate 
variability and cardiorespiratory fitness. All correlations were adjusted by degree of 
obesity, pubertal stage and BR (baseline when HRV and in effort when VO2peak was 
considered, respectively).”   
  
 
* In the revised version of the manuscript, subjects are categorized into hyperinsulinemic, 
hypertensive and perhaps in the original intention of the authors in dyslipidemic (in Methods is 
mentioned a category of "abnormal lipids" that however is not reported in Results). If the main 
result of the study is the association of insulin with cardiac autonomic neural activity, why the 
authors did not assess whether the autonomic dysfunction is more pronounced in hyperinsulinemia 
subjects? In any case, I would suggest to identify the "high insulin" levels using the reference values 
of insulin in a large population of children aged 7-20 years (Pediatrics 2012; 129, e1020). 
 
Data for the lipid profile were included as a baseline variable to exclude extreme dyslipemic 
subjects, such as familial hypercholesterolemia or other genetic causes, but they were not 
relevant for the purpose of the study. 
 
Hyperinsulinemia was defined following the criterion used in reference 24. In addition, we 
added the sources for the reference values (Goran and Gower, 2001; Alberti and Zimmet, 
1998). The use of other criteria, such as those recommended by the reviewer, does not add 
any relevant issues. To the contrary, the criteria used in the present study are more 
accepted by the scientific community. This is reflected by the number of the citations. Those  
recommended by the reviewer  have been poorly quoted in the literature (referenced on 
only 20 occasions). In contrast, the criteria used in the present study have been widely 




* Reference 24 for hyperinsulinism is incorrect and should be removed. The reference for adult 
WHO criteria of hyperinsulinism (>20 mU/l) is missing. 
 
Reference 24 has been replaced by Goran and Gower, 2001 (24); for adult criteria, Alberti 
and Zimmet, 1998 (25) has been added. 
 
* HOMA is incorrectly defined "homeostatic model assessment index" rather than HOMA-IR 
"homeostatic model assessment for insulin resistance". 
 
This semantic issue has been resolved. 
 
* The ref 20 should be updated with the latest 2016 European Society of Hypertension guidelines 
for the management of high blood pressure in children and adolescents 
 
The authors of the manuscript are quite aware of the new guidelines; however, the present 
research was undertaken well before their publication. They differ from the previous one in 
the definition of hypertension in subjects 16 years or older. That notwithstanding, use of the 
2016 guidelines resulted in no changes to the classification of the subjects. The reference of 
the Guidelines has been updated.  
 
* The reference 26 does not seem appropriate 
 
We are not in agreement with this comment. The paper is relevant and related to the topic 
of the present work. Moreover, the paper is included in Pubmed free for download and with 
impact factor. 
 
* The obesity index reported in Table 1 (height/waist ratio) is incorrect because the commonly used 
index of obesity is the waist/height ratio (for which there are reference data). 
 
This has been rectified.  
 
* Values in Table 1 and 2 should be adjusted for age and puberty (better if also for gender). Tanner 
stage (at least the % of prepubertal) should be included in Table 1. 
 
In our opinion, the suggested adjustments add no relevance, particularly when no 
differences in age or gender exist.  
 
The percentage of the prepubertal stage has been included. 
 
* Figure 1 is confusing because the length of the sides of the triangle does not correspond to the r 
value. It should include the statistical significance. A multivariate analysis with HRV as dependent 
variable and CRF, insulin, w/h and Tanner stage (or with insulin as dependent variable) should 
clarify the relationships among these factors 
 
Figure 1 is conceptual and not a mathematical expression. Multivariant analysis relating the 
three components, metabolic (insulin levels), HRV (LS_LF/HF) and the CRF (VO2peak) has been 
performed. Insulin levels were independently related to LF/HF (p=0.003), VO2peak (p=0.028), 
pubertal stage (p=0.014) and BR at exercise (p=0.016). These factors explain 35% of the 
variance.  
 
Multiple regression analysis table: factors related to insulin levels 
 
 
 Beta coefficient P value R2 
   0.35 
LF/HF 0.393 0.003  
VO2peak -0.293 0.028  
Pubertal stage 0.309 0.014  
BR at exercise 0.319 0.016  
 
 
This data has been included on Page 12, paragraph two. “Multivariant analysis relating the 
three components, metabolic (insulin levels), HRV (LS_LF/HF) and the CRF (VO2peak) and 
confounders, has been performed. Insulin levels were independently related to LF/HF 
(p=0.003), VO2peak (p=0.028), pubertal stage (p=0.014) and BR at exercise (p=0.016). These 
factors explain 35% of the variance.”  
 
* In the Discussion, page 12 line 6, "independently of obesity degree and puberty" instead of 
"independently of obesity degree"; page 12 line 9 eliminate "and non-diabetic individuals were 
present"; the last 6 lines of page 12 should be deleted. Page 13 line 4 "hyperinsulinemia" should be 
replaced with "insulin levels". Page 14 "Autonomic nervous system imbalance, assessed in the 
heart, may not only contribute to the development or stabilization of obesity (add reference) but is 
also associated with cardiovascular mortality (add reference)". Page 15 line 4 the description of 
Baum et al results should be expanded (her results are not completely in accord with the results of 
this study). 
 
The suggested changes have been made: 
 
page 13 line 1, "independent of the degree of obesity and of puberty" instead of 
"independently of obesity degree." 
 
page 13 line 4, eliminate "and non-diabetic individuals were present." 
 
The last 6 lines of the first paragraph in Discussion should be deleted: We believe that they 
clarify concepts to readers, not experts in the field. 
 
Page 13 line 14, "hyperinsulinemia" should be replaced with "insulin levels." 
 
Page 15  The references requested have been added: "Autonomic nervous system 
imbalance, assessed in the heart, may not only contribute to the development or 
stabilization of obesity (Bahler L, Molenaars RJ, Verberne HJ, Holleman F. Role of the 
autonomic nervous system in activation of human brown adipose tissue: A review of the 
literature. Diabetes Metab. 2015;41:437-445; Thorp AA, Schlaich MP. Relevance of 
Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome. J Diabetes 
Res. 2015;2015:341583), but it is also associated with cardiovascular mortality (Wulsin LR, 
Horn PS, Perry JL, Massaro JM, D'Agostino RB. Autonomic Imbalance as a Predictor of 
Metabolic Risks, Cardiovascular Disease, Diabetes, and Mortality. J Clin Endocrinol Metab. 
2015;100:2443-2448)." 
 
Page 15 line 4 the description of Baum et al. results has been expanded. Page 15, second 
paragraph, “These data are partially in agreement with those of the study by Baum 
et al. in which an ANS dysfunction was described in obese children and 
adolescents [45]. Autonomic nervous system dysfunction was characterized by 
both parasympathetic and sympathetic activity reduction, although the LF/LH ratio 
was positively related to body weight. Similarly, cANS abnormalities were 
observed in pre-obese and obese young adults [46]. 
 
 
* Several sentences of the manuscript are incomplete or disconnected (third last line of page 5, last 
sentence of page 6, first line of page 7) 
 
The manuscript has been reviewed for the incomplete or disconnected sentences: 
 
“…even though they have a higher degree of obesity, and as a consequence the concept of 
“healthy” obese has been proposed [11].” 
 
“While HRV was performed exclusively under resting conditions from the recorded ECG 
signal, the CRF was evaluated as oxygen consumption during the effort test.” 
 
 
      
 
 
Prof. Alberto Zanchetti,  
Editor-in-Chief 
Journal of Hypertension,  
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For the consideration of the Editorial Board of Journal of Hypertension, please 
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Table 1. General characteristics of the study population grouped by overweight and degree 
of obesity  
 
Values are average ± standard deviation. BMI body mass index,  HDL, high-density lipoprotein; 
HOMA, homeostatic model assessment; LDL, low-density lipoprotein; VO2, oxygen 
consumption¸ SBP systolic blood pressure; DBP Diastolic Blood Pressure; brpm breath per 
minute; bpm beat per minute;  P < 0.05. 
*denotes significant differences among groups  
Ω denotes significant differences with overweight 
¥ denotes significant differences with moderate obese 
 





Subjects, n (%) 14 (22) 33 (51) 17 (27)  
Sex (M/F) 10/4 18/15 13/4     0.244 
Age (years) 12.8 ± 1.1 12.0 ± 2.0 11.7 ± 2.4      0.260 
Weight (kg) 65.2 ± 9. 9 66.8 ± 15.0 84.3 ± 18.1¥ Ω 0.000* 
Height (cm) 162.4 ± 11.0  152.6 ± 10.8  Ω 157.6 ± 11.8 0.024* 
BMI (kg/m2) 24.6 ± 1.2 28.2 ± 3.0 Ω 33.5 ± 3.5¥ Ω 0.000* 
Waist (cm) 90.0 ± 6.3 93.2 ± 12.0 Ω 103.9 ± 8.2¥ Ω 0.000* 
Waist/Height   0.56 ± 0.03 0.61 ± 0.06 Ω 0.66 ± 0.0.4¥ Ω 0.000* 
Prepubertal stage, n (%) 5 (36) 16 (48) 11 (65)  
Hypertension, n 1 3 2  
 
Metabolic 
    Fasting glucose (mg/dl) 84.6 ± 6.3 85.4 ± 6.3 87.0 ± 6.5 0.564 
Fasting insulin (mU/ml) 10.0 ± 4.2 13.3 ± 12.0 17.0 ± 8.0 0.154 
HOMA Index 2.1 ± 1.0 2.8 ± 2.8 3.2± 2.0 0.258 
LDL cholesterol (mg/dl) 96.7 ± 29.0 93.3 ± 24.3 98.1 ± 18.4 0.773 
HDL cholesterol(mg/dl) 47.5 ± 10.9 47.0 ± 9.6 45.8 ± 9.1 0.872 
Triglycerides (mg/dl) 100.3 ± 48.0 83.5 ± 32.0 95.7 ± 40.3 0.317 
 
Resting Conditions 
    Breath rate (brpm) 13.0 ± 4.9 14.1 ± 6.1 13.7 ± 6.6 0.863 
SBP (mmHg) 108.1 ± 8.7 110.6 ± 11.4 114.1 ± 10.6 0.293 
DBP (mmHg) 63.7 ± 9.9 65.7 ± 8.8 66.6 ± 20.4 0.825 
Heart rate (bpm) 75.0 ± 11.0 73.3 ± 23.1 81.8 ± 20.2 0.392 
 
Effort Conditions 
    VO2 (mlO2/min*kg) 31.3 ± 7.1  26.9 ± 3.8 Ω 24.5 ± 5.3¥ 0.001* 
Breath rate (brpm) 41.7 ± 13.5 41.4 ± 8.7 50.0 ± 14.0¥ 0.037* 
SBP (mmHg) 130.4 ± 12.9 130.1 ± 13.8 133.1 ± 14.9 0.758 
DBP (mmHg) 68.4 ± 5.7 72.8 ± 8.4 78.3 ± 8.0¥ 0.003* 
     
Table
Table 2. Heart rate variability parameters grouped by overweight and obesity degree (n=64) 
 
    Obese   
Parameters Overweight Moderate Severe p-value 
Number 14 33 17   
Time domain 
SDNN (ms) 178.63 ± 156.22 211.38 ± 201.06 136.21 ± 86.22 0.303 
Frequency domain 
LS_LF(ms2) 0.01 ± 0.01 0.01 ± 0.01 0.01 ± 0.01 0.814 
LS_HF(ms2) 0.04 ± 0.04 0.02 ± 0.01  0.06 ± 0.04 ¥ 0.005* 
LS_Total(ms2) 0.06 ± 0.04 0.05 ± 0.02 0.07 ± 0.05 0.062 
LS_LF (n.u) 0.28 ± 0.11 0.32 ± 0.12 0.25 ± 0.16 0.171 
LS_HF (n.u) 0.72 ± 0.11 0.68 ± 0.11 0.75 ± 0.16 0.171 
LS_LF/HF  0.43 ± 0.23  0.50 ± 0.35 0.47 ± 0.53 0.849 
Non-linear dynamics 
Poincare S1 (ms) 153.19 ± 159.76 178.02 ± 188.14 103.49 ± 74.95 0.272 
Poincare S2 (ms) 198.67 ± 155.64 238.69 ± 214.89 160.85 ± 99.06 0.315 
Sample entropy 1.40 ± 0.45 1.33 ± 0.52 1.36 ± 0.39 0.916 
DFA short term 0.74 ± 0.21 0.74 ± 0.16 0.75 ± 0.21 0.977 
DFA long term 0.71 ± 0.17 0.77 ± 0.17 0.73 ± 0.21 0.548 
SDNN standard deviation of the NN interval series; ms miliseconds 
LS denotes the Lomb-Scargle method to calculate frequency domain parameters 
LF low frequency; HF high frequency 
ms2 power; n.u normalized values 
DFA detrended fluctuation analyses 
*denotes significant differences among groups  
¥ denotes significant differences with moderate overweight 
Table
 
Table 3. Pearson´s correlation coefficients among heart rate variability parameters, insulin and cardiorespiratory fitness in normotensives, adjusted by 
confounders (n=58)  
 
 
 Time domain  Frequency domain 
 
 Non linear dynamics 
 




















DFA   
α2 
 
Adjusted by obesity degree, pubertal stage and baseline respiration rate  
Metabolic profile              
Insulin (mU/ml) -0.009  0.099 0.086 0.096 0.131 -0.131 0.281*  -0.000 -0.013 -0.054 0.109 -0.181 
HOMA index -0.010  0,145 0.079 0.094 0.162 -0.162 0.304*  -0.005 -0.012 -0.079 0.172 -0.138 
               
Resting conditions              
Systolic BP (mmHg) -0.208  0.072 0.040 0.044 0.086 -0.086 -0.132  -0.210 -0.208 0.117 0.181 0.128 
Diastolic BP (mmHg) -0.058  0.185 0.064 0.105 0.012 -0.012 -0.054  -0.065 -0.045 -0.053 0.273 0.082 
 
Adjusted by obesity degree and effort respiration rate 
Effort test              
Systolic BP (mmHg) -0.240  0.022 -0.061 -0-074 -0.089 0.089 -0.084  -0.243 -0.238 0.211 0.091 0.184 
Diastolic BP (mmHg) 0.081  -0.065 -0.170 -0.149 -0.088 0.088 -0.161  0.101 0.061 0.094 -0.026 0.078 
(VO2)peak 0.268*  0.015 -0.140 -0.094 0.150 -0.150 0.138  0.275* 0.273* -0.198 -0.098 0.080 
BP blood pressure.  HOMA homeostatic model assessment 
SDNN standard deviation of the NN interval series; ms miliseconds 
LS denotes the Lomb-Scargle method to calculate frequency domain parameters LF low frequency; HF high frequency 
ms2 power; n.u normalized values 
DFA detrended fluctuation analyses *denotes statistical significant (p<0.05) 
Table
